![David Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Slack
Directeur Général chez
Cend Therapeutics, Inc.
Profil
David Slack is currently the President, Chief Executive Officer & Director at Cend Therapeutics, Inc. He is also the Chairman at Lisata Therapeutics Australia Pty Ltd. Previously, he held positions such as Director-Technology Alliances & Licensing at Aventis Pharmaceuticals, Inc. and Rhone-Poulenc Rorer Pharmaceuticals, Inc. He was also the Vice President-Business Development at Ionis Pharmaceuticals, Inc. and the Chief Business Officer at Viracta Subsidiary, Inc. Additionally, he worked as a Principal at DS Lifescience Consulting.
Mr. Slack's education includes an undergraduate degree from California State University-Sacramento and an MBA from Monterey Institute of International Studies.
Postes actifs de David Slack
| Sociétés | Poste | Début |
|---|---|---|
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Directeur Général | 08/07/2020 |
Lisata Therapeutics Australia Pty Ltd. | Président | - |
Anciens postes connus de David Slack
| Sociétés | Poste | Fin |
|---|---|---|
| LISATA THERAPEUTICS, INC. | President | 01/05/2023 |
DS Lifescience Consulting | Corporate Officer/Principal | 01/03/2021 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Corporate Officer/Principal | 01/07/2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2004 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/2000 |
Formation de David Slack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
California State University-Sacramento
 California State University-Sacramento Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monterey Institute of International Studies
 Monterey Institute of International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company that provides treatment for tumor cancers | Health Technology |
Lisata Therapeutics, Inc.
 Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Lisata Therapeutics Australia Pty Ltd. | |
DS Lifescience Consulting |
